These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 9178774)

  • 1. Encouraging trend on prescription drug information.
    Marwick C
    JAMA; 1997 Jun; 277(22):1746-7. PubMed ID: 9178774
    [No Abstract]   [Full Text] [Related]  

  • 2. Prescription drug products; patient labeling requirements: proposed rule.
    Fed Regist; 1979 Jul; 44(131 Pt 2):40015-41. PubMed ID: 10242793
    [No Abstract]   [Full Text] [Related]  

  • 3. The National Council on Patient Information and Education.
    Sasich LD; Wolfe SM; Pearson C; Swankin DA; Levin AA; Beard J
    JAMA; 1997 Nov; 278(18):1491-2. PubMed ID: 9363963
    [No Abstract]   [Full Text] [Related]  

  • 4. MedGuide: at last a long-sought opportunity for patient education about prescription drugs.
    Marwick C
    JAMA; 1997 Mar; 277(12):949-50. PubMed ID: 9091654
    [No Abstract]   [Full Text] [Related]  

  • 5. The patient package insert--health care provider's friend or foe?
    Hirsh HL
    Nurs Homes; 1979; 28(4):24-5. PubMed ID: 10283734
    [No Abstract]   [Full Text] [Related]  

  • 6. Prescription drug product labeling; medication guide requirements--FDA. Final rule.
    Fed Regist; 1998 Dec; 63(230):66378-400. PubMed ID: 10338877
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Food and Drug Administration--Prescription drug products; patient package inserts requirements. Final rule.
    Fed Regist; 1980 Sep; 45(179 Pt 2):60754-84. PubMed ID: 10248285
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Requirements for FDA-approved patient information spelled out in final rule.
    Am J Health Syst Pharm; 1999 Jan; 56(2):107-8. PubMed ID: 10030523
    [No Abstract]   [Full Text] [Related]  

  • 9. Improving prescription drug labeling.
    Wolf MS; Bailey SC
    N C Med J; 2007; 68(5):340-2. PubMed ID: 18183755
    [No Abstract]   [Full Text] [Related]  

  • 10. Advice for the dispensing physician.
    Blake MI; Slotnik LB
    IMJ Ill Med J; 1980 Aug; 158(2):65-8. PubMed ID: 6105145
    [No Abstract]   [Full Text] [Related]  

  • 11. Should expiration dates be required on patients' prescription labels?
    Hadeler F
    Am Pharm; 1986 Aug; NS26(8):30-5. PubMed ID: 3776829
    [No Abstract]   [Full Text] [Related]  

  • 12. Prescription drug products; revocation of patient package insert requirements--Food and Drug Administration. Final rule.
    Fed Regist; 1982 Sep; 47(173):39147-55. PubMed ID: 10258154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Imported/foreign COCs.
    Bumpstead E
    J Fam Plann Reprod Health Care; 2006 Apr; 32(2):135. PubMed ID: 16824325
    [No Abstract]   [Full Text] [Related]  

  • 14. "Use as Directed" Can Cause Confusion for Both Patients and Practitioners.
    Shastay A
    Home Healthc Now; 2018; 36(2):128-130. PubMed ID: 29498995
    [No Abstract]   [Full Text] [Related]  

  • 15. Patient package inserts: the proper prescription?
    Rowe HM
    Food Drug Law J; 1995; 50(1):95-124. PubMed ID: 10342988
    [No Abstract]   [Full Text] [Related]  

  • 16. Medication safety issue brief. Counterfeit drug prevention and identification.
    ; ;
    Hosp Health Netw; 2005 Aug; 79(8):29-30. PubMed ID: 16247941
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Literacy and misunderstanding prescription drug labels.
    Katz D
    Ann Intern Med; 2007 Aug; 147(4):281. PubMed ID: 17709766
    [No Abstract]   [Full Text] [Related]  

  • 18. To inform or persuade? Direct-to-consumer advertising of prescription drugs.
    Berndt ER
    N Engl J Med; 2005 Jan; 352(4):325-8. PubMed ID: 15673797
    [No Abstract]   [Full Text] [Related]  

  • 19. Invited commentary--prescription drug label adverse events: a call for prioritization: comment on "A quantitative analysis of adverse events and 'overwarning' in drug labeling".
    Cheng C; Guglielmo BJ
    Arch Intern Med; 2011 May; 171(10):946-7. PubMed ID: 21606102
    [No Abstract]   [Full Text] [Related]  

  • 20. Use of approved drugs for unlabeled indications.
    FDA Drug Bull; 1982 Apr; 12(1):4-5. PubMed ID: 7075926
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.